Aquestive Therapeutics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

4Oct. 23, 2026, 1:38 p.m. ETView on SEC.gov
8-KOct. 19, 2026, 4:04 p.m. ETView on SEC.gov
Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
AI summary, unreviewedAquestive Therapeutics Amends Bylaws to Remove Concert-Action Nomination Disclosure Requirements; No Financial Impact Disclosed
4Oct. 16, 2026, 2:17 p.m. ETView on SEC.gov
8-KOct. 15, 2026, 7:21 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedAquestive Therapeutics Gets FDA Acceptance of Anaphylm NDA Resubmission, PDUFA Date Set for March 16, 2027
8-KOct. 14, 2026, 7:21 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Financial statements and exhibits
SCHEDULE 13GOct. 7, 2026, 3:47 p.m. ETView on SEC.gov
SCHEDULE 13G/AOct. 7, 2026, 2:14 p.m. ETView on SEC.gov
8-KSept. 29, 2026, 7:22 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
8-KSept. 25, 2026, 7:59 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KSept. 17, 2026, 7:02 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
4Sept. 16, 2026, 2 p.m. ETView on SEC.gov
4Sept. 11, 2026, 11:07 a.m. ETView on SEC.gov
4Sept. 10, 2026, 9:21 a.m. ETView on SEC.gov
4Sept. 9, 2026, 5:10 p.m. ETView on SEC.gov
4Sept. 8, 2026, 4:06 p.m. ETView on SEC.gov
4Aug. 18, 2026, 4:13 p.m. ETView on SEC.gov
4Aug. 17, 2026, 5:33 p.m. ETView on SEC.gov
10-QAug. 11, 2026, 4:10 p.m. ETView on SEC.gov
8-KAug. 11, 2026, 4:06 p.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 10, 2026, 7:05 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
SCHEDULE 13G/AJuly 27, 2026, 4:25 p.m. ETView on SEC.gov